Pulmonary complications of bone-marrow and stem-cell transplantation

Bekele Afessa, Andrew David Badley, Steve G. Peters

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Tens of thousands of patients undergo haematopoietic stem-cell transplantation (HSCT) annually, primarily for haematological and lymphoid cancers, but also for other disorders.1 Intensive care support is provided for 15-40 per cent of HSCT recipients, most of whom require mechanical ventilation for respiratory failure.2 Although recent studies have shown improvement in outcome, the mortality rate of HSCT recipients receiving invasive ventilation may exceed 90 per cent. This chapter describes the pulmonary complications that develop in HSCT recipients.

Original languageEnglish (US)
Title of host publicationDrug-Induced and Iatrogenic Respiratory Disease
PublisherCRC Press
Pages172-191
Number of pages20
ISBN (Electronic)9781444128697
ISBN (Print)9780340809730
StatePublished - Jan 1 2010

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Environmental Science(all)

Cite this

Afessa, B., Badley, A. D., & Peters, S. G. (2010). Pulmonary complications of bone-marrow and stem-cell transplantation. In Drug-Induced and Iatrogenic Respiratory Disease (pp. 172-191). CRC Press.